Literature DB >> 22045345

Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials.

Justin J O'Hagan, Miguel A Hernán, Rochelle P Walensky, Marc Lipsitch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22045345      PMCID: PMC3319457          DOI: 10.1097/QAD.0b013e32834e1ce7

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  35 in total

Review 1.  Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.

Authors:  Dirk Bassler; Matthias Briel; Victor M Montori; Melanie Lane; Paul Glasziou; Qi Zhou; Diane Heels-Ansdell; Stephen D Walter; Gordon H Guyatt; David N Flynn; Mohamed B Elamin; Mohammad Hassan Murad; Nisrin O Abu Elnour; Julianna F Lampropulos; Amit Sood; Rebecca J Mullan; Patricia J Erwin; Clare R Bankhead; Rafael Perera; Carolina Ruiz Culebro; John J You; Sohail M Mulla; Jagdeep Kaur; Kara A Nerenberg; Holger Schünemann; Deborah J Cook; Kristina Lutz; Christine M Ribic; Noah Vale; German Malaga; Elie A Akl; Ignacio Ferreira-Gonzalez; Pablo Alonso-Coello; Gerard Urrutia; Regina Kunz; Heiner C Bucher; Alain J Nordmann; Heike Raatz; Suzana Alves da Silva; Fabio Tuche; Brigitte Strahm; Benjamin Djulbegovic; Neill K J Adhikari; Edward J Mills; Femida Gwadry-Sridhar; Haresh Kirpalani; Heloisa P Soares; Paul J Karanicolas; Karen E A Burns; Per Olav Vandvik; Fernando Coto-Yglesias; Pedro Paulo M Chrispim; Tim Ramsay
Journal:  JAMA       Date:  2010-03-24       Impact factor: 56.272

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

3.  Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?

Authors:  Adrián V Hernández; Marinus J C Eijkemans; Ewout W Steyerberg
Journal:  Ann Epidemiol       Date:  2005-11-07       Impact factor: 3.797

4.  Estimation of individual and population vaccination effectiveness from time-to-event data.

Authors:  M Haber; A Ndikuyeze
Journal:  Stat Med       Date:  1998-11-30       Impact factor: 2.373

Review 5.  Should we adjust for covariates in nonlinear regression analyses of randomized trials?

Authors:  W W Hauck; S Anderson; S M Marcus
Journal:  Control Clin Trials       Date:  1998-06

6.  The impact of heterogeneity in individual frailty on the dynamics of mortality.

Authors:  J W Vaupel; K G Manton; E Stallard
Journal:  Demography       Date:  1979-08

7.  Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research.

Authors:  Y Moride; L Abenhaim; M Yola; A Lucein
Journal:  J Clin Epidemiol       Date:  1994-07       Impact factor: 6.437

Review 8.  The evolving concept of the healthy worker survivor effect.

Authors:  H M Arrighi; I Hertz-Picciotto
Journal:  Epidemiology       Date:  1994-03       Impact factor: 4.822

9.  The hazards of hazard ratios.

Authors:  Miguel A Hernán
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

10.  A Bayesian Framework for Estimating Vaccine Efficacy per Infectious Contact.

Authors:  Yang Yang; Peter Gilbert; Ira M Longini; M Elizabeth Halloran
Journal:  Ann Appl Stat       Date:  2008       Impact factor: 2.083

View more
  17 in total

1.  Depletion-of-susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine Effectiveness.

Authors:  G Thomas Ray; Ned Lewis; Nicola P Klein; Matthew F Daley; Marc Lipsitch; Bruce Fireman
Journal:  Clin Infect Dis       Date:  2020-03-17       Impact factor: 9.079

2.  Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study.

Authors:  Shuo Feng; Susan S Chiu; Eunice L Y Chan; Mike Y W Kwan; Joshua S C Wong; Chi-Wai Leung; Yiu Chung Lau; Sheena G Sullivan; J S Malik Peiris; Benjamin J Cowling
Journal:  Lancet Respir Med       Date:  2018-11-12       Impact factor: 30.700

3.  Measurement of Vaccine Direct Effects Under the Test-Negative Design.

Authors:  Joseph A Lewnard; Christine Tedijanto; Benjamin J Cowling; Marc Lipsitch
Journal:  Am J Epidemiol       Date:  2018-12-01       Impact factor: 4.897

4.  Estimating the effectiveness in HIV prevention trials by incorporating the exposure process: application to HPTN 035 data.

Authors:  Jingyang Zhang; Elizabeth R Brown
Journal:  Biometrics       Date:  2014-05-20       Impact factor: 2.571

5.  Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies.

Authors:  Marc Lipsitch; Ayan Jha; Lone Simonsen
Journal:  Int J Epidemiol       Date:  2016-12-01       Impact factor: 7.196

Review 6.  Temporally Varying Relative Risks for Infectious Diseases: Implications for Infectious Disease Control.

Authors:  Edward Goldstein; Virginia E Pitzer; Justin J O'Hagan; Marc Lipsitch
Journal:  Epidemiology       Date:  2017-01       Impact factor: 4.822

7.  Estimating effectiveness in HIV prevention trials with a Bayesian hierarchical compound Poisson frailty model.

Authors:  Rebecca Yates Coley; Elizabeth R Brown
Journal:  Stat Med       Date:  2016-02-11       Impact factor: 2.373

8.  Estimating the per-exposure effect of infectious disease interventions.

Authors:  Justin J O'Hagan; Marc Lipsitch; Miguel A Hernán
Journal:  Epidemiology       Date:  2014-01       Impact factor: 4.822

9.  Joint modeling of time-varying HIV exposure and infection for estimation of per-act efficacy in HIV prevention trials.

Authors:  Elizabeth R Brown; Clara P Dominguez Islas; Jingyang Zhang
Journal:  Stat Commun Infect Dis       Date:  2020-09-24

10.  Interpreting vaccine efficacy trial results for infection and transmission.

Authors:  Marc Lipsitch; Rebecca Kahn
Journal:  Vaccine       Date:  2021-06-12       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.